XML 53 R41.htm IDEA: XBRL DOCUMENT v3.23.1
Investments in Non-Marketable Securities - Narrative (Details) - USD ($)
1 Months Ended 3 Months Ended
Mar. 31, 2023
Sep. 30, 2021
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Marketable Securities [Line Items]          
Payments to acquire other investments     $ 750,000 $ 5,000,000  
Total non-marketable equity securities $ 21,310,000   21,310,000   $ 20,510,000
Total revenues     12,982,000 35,340,000  
Unrealized or realized gains or losses     0 0  
Research and development revenue ($0 and $245 from a related party)          
Marketable Securities [Line Items]          
Total revenues     4,618,000 4,650,000  
seqWell | Research and development revenue ($0 and $245 from a related party)          
Marketable Securities [Line Items]          
Total revenues     $ 50,000    
Common Stock | seqWell          
Marketable Securities [Line Items]          
Shares issued in exchange for service (in shares)     47,933    
seqWell          
Marketable Securities [Line Items]          
Total non-marketable equity securities 5,050,000   $ 5,050,000 $ 5,000,000 5,000,000
Arzeda          
Marketable Securities [Line Items]          
Total non-marketable equity securities $ 1,289,000   $ 1,289,000   $ 1,289,000
Series A And B Preferred Stock | MAI | MCRA          
Marketable Securities [Line Items]          
Number of shares received in exchange for services (in shares)     19,277,914    
Series C Preferred Stock | seqWell          
Marketable Securities [Line Items]          
Non-marketable equity securities purchased (in shares)       1,000,000  
Series B-2 Preferred Stock | Arzeda          
Marketable Securities [Line Items]          
Non-marketable equity securities purchased (in shares) 207,070   207,070    
MAI | Series B Preferred Stock          
Marketable Securities [Line Items]          
Number of shares purchased (in shares) 985,545 9,198,423 985,545    
Payments to acquire other investments $ 800,000 $ 7,000,000